Nasdaq: ELVN
Enliven Therapeutics insiders
The officers, directors and 10% owners of Enliven Therapeutics, Inc. who hold the most stock, valued at the live ELVN price.
$46.41
ELVN today +$1.5M (+3.39%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 11
- Their ELVN stock
- $713M
- Market value
- $3.42B
- Held by ranked insiders
- 20.9%
Insiders by value of ELVN holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Nea 14 Gp, LTD | 10% owner | 3,538,940 | $164M | 4.81% | Corporate |
| 2 | New Enterprise Associates 14, L.P. | 10% owner | 3,305,601 | $153M | 4.49% | Corporate |
| 3 | NEA Partners 14, L.P. | 10% owner | 2,611,050 | $121M | 3.55% | Corporate |
| 4 | Mark Chin | Director | 2,344,072 | $109M | 3.19% | 1385th |
| 5 | Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | 1,751,596 | $81.3M | 2.38% | 1765th |
| 6 | Samuel Kintz | PRESIDENT AND CEO | 890,392 | $41.3M | 1.21% | 2926th |
| 7 | Anish Patel | CHIEF OPERATING OFFICER | 235,011 | $10.9M | 0.32% | 8208th |
| 8 | Braden M Leonard | 10% owner | 230,000 | $10.7M | 0.31% | 7717th |
| 9 | David M. Mott | Director | 229,224 | $10.6M | 0.31% | 4905th |
| 10 | Richard A. Heyman | Director | 146,320 | $6.8M | 0.20% | 9780th |
| 11 | Jake Bauer | Director | 87,372 | $4.1M | 0.12% | 13857th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Enliven Therapeutics; see each profile for the filing.